CODX vs TPR
Co-Diagnostics, Inc. Common Stock (CODX) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
CODX currently screens at market cap $31.4M. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the CODX and TPR stock pages for the full models.
Not investment advice.